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Background: Central nervous system (CNS) invasion by bacteria of the genus Brucella results in an inflammatory
disorder called neurobrucellosis. We have recently demonstrated that B. abortus infects microglia and astrocytes,
eliciting the production of a variety of pro-inflammatory cytokines which contribute to CNS damage. Matrix
metalloproteinases (MMP) have been implicated in inflammatory tissue destruction in a range of pathological
situations in the CNS. Increased MMP secretion is induced by pro-inflammatory cytokines in a variety of CNS
diseases characterized by tissue-destructive pathology.
Methods: In this study, the molecular mechanisms that regulate MMP secretion from Brucella-infected astrocytes
in vitro were investigated. MMP-9 was evaluated in culture supernatants by ELISA, zymography and gelatinolytic
activity. Involvement of mitogen-activated protein kinases (MAPK) signaling pathways was evaluated by Western
blot and using specific inhibitors. The role of TNF-α was evaluated by ELISA and by assays with neutralizing
antibodies.
Results: B. abortus infection induced the secretion of MMP-9 from murine astrocytes in a dose-dependent fashion.
The phenomenon was independent of bacterial viability and was recapitulated by L-Omp19, a B. abortus
lipoprotein model, but not its LPS. B. abortus and L-Omp19 readily activated p38 and Erk1/2 MAPK, thus enlisting
these pathways among the kinase pathways that the bacteria may address as they invade astrocytes. Inhibition of
p38 or Erk1/2 significantly diminished MMP-9 secretion, and totally abrogated production of this MMP when both
MAPK pathways were inhibited simultaneously. A concomitant abrogation of B. abortus- and L-Omp19-induced
TNF-α production was observed when p38 and Erk1/2 pathways were inhibited, indicating that TNF-α could be
implicated in MMP-9 secretion. MMP-9 secretion induced by B. abortus or L-Omp19 was completely abrogated
when experiments were conducted in the presence of a TNF-α neutralizing antibody. MMP-9 activity was detected
in cerebrospinal fluid (CSF) samples from patients suffering from neurobrucellosis.
Conclusions: Our results indicate that the inflammatory response elicited by B. abortus in astrocytes would lead to
the production of MMP-9 and that MAPK may play a role in this phenomenon. MAPK inhibition may thus be
considered as a strategy to control inflammation and CNS damage in neurobrucellosis.
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Human brucellosis is a protean disease with a diversity
of clinical signs and symptoms resulting from infection
with Brucella species [1]. It is chiefly an inflammatory
disease. Inflammation is present both in the acute and
chronic phases of the disease and in virtually all of the
organs affected. Clinical signs of such inflammation are
undulant fever, endocarditis, arthritis, osteomyelitis, menin-
gitis, pleocytosis, cellular infiltration of the joints, orchitis,
nephritis, hepatic granuloma, etc [2]. In the central nervous
system (CNS), where the function of neurons is normally
protected by the maintenance of an antiinflammatory envir-
onment [3], infection with Brucella leads to an inflamma-
tory disorder called neurobrucellosis which involves tissue
destruction [4,5]. The underlying mechanisms of this
phenomenon are currently unclear. Yet, a better under-
standing of the pathogenesis of neurobrucellosis would help
if improvements are to be made on therapies that help to
cure or ameliorate this form of the disease [6].
Matrix metalloproteinases (MMP) are a family of
calcium- and zinc-dependent proteinases that have been
implicated in inflammatory tissue destruction in a range
of pathological situations in the CNS, including experi-
mental autoimmune encephalomyelitis, multiple scler-
osis, and CNS tuberculosis [7-10]. Particularly, MMP-9
can degrade many structural components of the blood-
brain barrier and CNS tissue matrix, including type IV
collagen, laminins, and fibronectin [11,12]. MMP-9 can
also mediate direct damage to neurons [13] and MMP-9
knockout mice are protected against ischemic and post-
traumatic damage which follows blood-brain barrier
disruption [14]. In addition, MMP have been implicated
in tissue-destructive pathology in osteoarticular brucel-
losis [15-18].
Astrocytes are the most numerous cell type within the
CNS, outnumbering neurons by a factor of ten. They are
integral to both maintenance of the CNS tissue matrix
and innate immunity within the CNS [19], and also the
well-being of the blood-brain barrier [20,21]. In normal
physiology MMP-9 secretion is highly regulated, and
under these conditions astrocyte-derived MMP-9 partic-
ipates in tissue remodeling and neurite extension
[22,23]. Yet, astrocyte-derived MMP-9 may contribute to
the development of a tissue-destructive phenotype in the
CNS. Increased MMP-9 secretion is induced by pro-
inflammatory cytokines in a range of CNS diseases char-
acterized by tissue-destructive pathology [24].
We have recently demonstrated that upon infection
with B. abortus, astrocytes have a key role in eliciting a
pro-inflammatory cytokine response (TNF-α, IL-1β and
IL-6) that leads to astrogliosis in vivo and in vitro [25].
However, the role that astrocytes play in control of
MMP-9 secretion and its potential in inflammatory tis-
sue destruction in neurobrucellosis is unknown.Mitogen-activated protein kinases (MAPK) play a key
role in the regulation of neuronal development, growth,
and survival, as well as in pro-inflammatory cytokine
production. The Erk1/2 pathway is mainly associated
with neuronal development, whereas the p38 kinase is a
stress-activated kinase that participates in the regulation
of pro-inflammatory cytokines and apoptosis [26]. Erk1/
2 have been implicated in astrogliosis [27,28], and bac-
terial lipopolysaccharide (LPS) has been shown to induce
IL-6 and TNF-α in both astrocytes and microglia by acti-
vating Erk1/2 and p38 [29]. Moreover, Mycobacterium tu-
berculosis regulates MAPK-dependent astrocyte MMP-9
secretion [30].
In this study, we investigated the cytokine network
that regulates MMP secretion from Brucella-infected as-
trocytes and examined the MAPK signaling pathways in-
volved. Results are discussed in the context of CNS
damage in neurobrucellosis.
Methods
Animals
For the primary cultures of astrocytes, one- to three-day-old
BALB/c mice (Instituto de Estudios de la Inmunidad
Humoral (IDEHU), Facultad de Farmacia y Bioquímica,
Universidad de Buenos Aires, Buenos Aires, Argentina)
were used. Animals were obtained from breeding couples
housed under controlled temperature (22°C ± 2°C) and
artificial light under a 12-hour cycle period. Mice were
kept under specific pathogen-free conditions in a positive-
pressure cabinet (EHRET, Emmendingen, Germany) and
provided with sterile food and water ad libitum. All ani-
mal procedures were performed according to the rules
and standards for the use of laboratory animals of the Na-
tional Institute of Health, USA. Animal experiments were
approved by the ethics committee of the IDEHU Institute.
Bacterial culture
B. abortus S2308, B. canis, B. melitensis H38 and B. suis
1330 were grown overnight in 10 ml of tryptic soy broth
(TSB) with constant agitation at 37°C. Bacteria were
harvested by centrifugation for 15 minutes at 6,000 × g
at 4°C and washed twice in 10 ml of phosphate-buffered
saline (PBS). Bacterial numbers in the cultures were esti-
mated by comparing the optical densities at 600 nm with
a standard curve obtained in our laboratory. To prepare
inocula, cultures were diluted in sterile PBS to the de-
sired bacterial concentration on the basis of the optical
density readings, but the precise concentrations of inoc-
ula were determined by plating cells onto tryptic soy
agar. To obtain heat-killed B. abortus (HKBA), bacteria
were washed five times for 10 minutes each in sterile
PBS, heat-killed at 70°C for 20 minutes, aliquoted, and
stored at −70°C until they were used. The total absence
of B. abortus viability after heat killing was verified by
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live Brucella manipulations were performed in biosafety
level 3 facilities.
Lipoproteins and LPS
B. abortus lipidated outer membrane protein 19 (L-
Omp19) and unlipidated Omp19 (U-Omp19) were obtained
as described [31]. Both recombinant proteins contained less
than 0.25 endotoxin U/μg of protein as assessed by Limulus
Amebocyte Lysates (Associates of Cape Cod Inc., MA,
USA). B. abortus S2308 LPS was provided by I. Moriyon.
The synthetic lipohexapeptide (tripalmitoyl-S-glyceryl-Cys-
Ser-Lys4-OH (Pam3Cys)) was purchased from Boehringer
Mannheim (Mannheim, Germany).
Primary astrocyte culture
Highly pure astrocytes (> 95%) were established from
primary mixed glial cultures obtained from the forebrain
of one- to three-day-old BALB/c mice following previ-
ously published procedures [25].
In vitro infection
Astrocytes were cultured in 24 well plates at a density of
5 × 105 cells per well in DMEM high glucose (Hyclone,
Logan, Utah, USA) containing 10% heat inactivated FBS
(GIBCO BRL, Life Technologies, Grand Island, NY,
USA), supplemented with 2 mM L-glutamine and 1 mM
sodium without the addition of antibiotics. Cells were
infected with B. abortus (at different multiplicities of in-
fection (MOI)), B. melitensis, B. canis or B. suis (MOI
100: 1) for two hours in medium containing no antibi-
otics. Astrocytes were extensively washed to remove un-
internalized bacteria, and infection was maintained for
different times in the presence of 100 μg/ml gentamicin
and 50 μg/ml streptomycin to kill remaining extracellu-
lar bacteria. Cells were washed three times with PBS
before processing. To monitor Brucella intracellular
survival, infected cells were lysed with 0.1% (v/v) Triton
X-100 in H2O after PBS washing and serial dilutions of
lysates were plated onto TSB agar plates to enumerate
colony forming units (CFUs).
Assessment of cytokines and MMP secretion
Primary astroglial-enriched cultures were either infected
with different MOI or stimulated for 48 hours with B.
abortus LPS (1,000 ng/ml), HKBA (1 × 106 to 1 × 109
bacteria/ml), U-Omp19 (1,000 ng/ml), L-Omp19 (10 to
1,000 ng/ml), Pam3Cys (25 ng/ml), TNF-α (5 ng/ml)
(Pharmingen, San Diego, CA, USA) or phorbol myristate
acetate (PMA) (50 ng/ml). Secretion of TNF-α in the
supernatants was quantified by ELISA (Pharmingen, San
Diego, CA, USA). MMP was determined by ELISA,
zymography and gelatinolytic activity.Zymography
Gelatinase activity was assayed by the method of Hibbs
et al. [32], which was standardized by others [33-35].
Briefly, a total of 20 μl of cell culture supernatants from
infected astrocytes or from untreated controls, as well as
cerebrospinal fluid from patients with neurobrucellosis
were mixed with 5 μl of 5X loading buffer (0.25 M Tris
(pH 6.8), 50% glycerol, 5% SDS, and bromophenol blue
crystals) and loaded onto 10% SDS-PAGE gels containing
1 mg/ml gelatin (Sigma-Aldrich, Buenos Aires, Argentina).
Following electrophoresis, gels were washed with a solu-
tion containing 50 mM Tris-HCl (pH 7.5) and 2.5% Triton
X-100 (buffer A) for 30 minutes and with buffer A added
with 5 mM CaCl2 and 1 μM ZnCl2 for 30 minutes and
were later incubated with buffer A with additional 10 mM
CaCl2 and 200 mM NaCl for 48 hours at 37°C. This
denaturation/renaturation step promotes MMP activity
without the proteolytic cleavage of pro-MMP. Gelatin ac-
tivity was visualized by the staining of the gels with 0.5%
Coomassie blue. Unstained bands indicated the presence
of gelatinase activity, and their positions indicated the mo-
lecular weights of the enzymes involved. The identity of
the candidate MMP was confirmed by a specific ELISA.
Measurement of MMP-9 levels
MMP-9 levels present in culture supernatants from as-
trocytes were quantified by sandwich ELISA using paired
MMP-9-specific monoclonal antibodies according to the
manufacturer’s instructions (R&D Systems, Minneapolis,
MN, USA).
Gelatinase activity under native conditions
Gelatinase activity in unprocessed culture supernatants
(native conditions) was measured by using a gelatinase/
collagenase fluorometric assay kit (EnzChek; Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
instructions. The EnzChek kit contains DQ gelatin, a
fluorescein-conjugated gelatin so heavily labeled with
fluorescein that fluorescence is quenched. When this
substrate is digested by gelatinases or collagenases, it
yields highly fluorescent peptides, and the fluorescence
increase is proportional to the proteolytic activity. Colla-
genase purified from Clostridium histolyticum provided
in the assay kit served as a control enzyme. Plates were
read with a fluorescence plate reader (Victor3; Perkin-
Elmer, Waltham, MA, USA).
Signaling pathways
To study the potential involvement of different signaling
pathways in the production of MMP-9 and TNF-α by
astrocytes, pharmacological inhibitors (SB203580, a p38
MAPK inhibitor; PD98059, an Erk1/2 MAPK inhibitor;
and SP600125, a Jnk1/2 inhibitor) or vehicle (dimethyl
sulfoxide (DMSO)) were added two hours before the
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out. SB203580, PD98059 and SP600125 (Calbiochem,
San Diego, CA, USA) were used at a concentration of 6
μM, 50 μM and 10 μM, respectively; based on previous
reports [36]. Cell viability after incubation with these in-
hibitors was higher than 90%, as assessed by staining
with trypan blue. To account for any possible effect of
DMSO on cell viability, cell cultures not treated with the
inhibitors were treated with the highest final concentra-
tion of DMSO used in these studies (0.01%), and the
results were compared with those of cell cultures not ex-
posed to DMSO.
p38, Erk1/2 and Jnk1/2 activation by Western blot
Astrocytes treated with HKBA or L-Omp19 or stimu-
lated with PMA (positive control) were lysed in ice-cold
lysis buffer consisting of 1% Triton X-100 in 150 mM
NaCl, 25 mM Tris-HCl (TBS) pH 7.4, and protease and
phosphatase inhibitor cocktails (Sigma-Aldrich, Buenos
Aires, Argentina). Lysates were incubated on ice for 10
minutes and cleared by centrifugation at 13,000 × g for
10 minutes. Protein concentration was determined by
the bicinchoninic acid method (Pierce, Rockford, IL,
USA) using bovine serum albumin as standard, and
equal amounts of proteins were loaded onto electro-
phoresis gels. After separation, proteins were transferred
to a nitrocellulose membrane (GE Healthcare, Little
Chalfont, UK) and blocked for one hour with 0.1%
Tween-20. Then, membranes were incubated with pri-
mary anti-Erk1/2 and anti-p38 antibodies (total and
phosphorylated) (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) (1:1,000 dilution) or anti-Jnk1/2 antibodies
(Cell signaling Technology, Danvers, MA, USA) (1:1,000
dilution) overnight at 4°C. After washing, the membrane
was incubated with a 1:2,000 dilution of peroxidase-
conjugated secondary antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) for one hour. Protein bands were
visualized on ECLW (GE Healthcare, Little Chalfont, UK)
Hyperfilm by chemiluminescence.
Blocking of TNF-α
Neutralization experiments were performed with 20 μg/
ml of anti-TNF-α neutralizing antibody (clone MP6-XT3)
or its isotype control (Pharmingen, San Diego, CA, USA).
CSF and serum samples
CSF and serum samples were obtained from a) non-infected
controls (patients suspected of suffering Alzheimer’s
disease), b) patients who had neurobrucellosis (as
shown by signs and symptoms indicative of neurological
involvement, the isolation of Brucella spp. from CSF
samples, and the detection of anti-Brucella antibodies
in CSF by an agglutination or Coombs test), c) a patient
who had brucellosis without neurological involvement(this patient had signs and symptoms typical of brucel-
losis and was positive by standard Brucella serology,
and had severe headaches that motivated the extraction
of a CSF sample to rule out neurobrucellosis; however, this
CSF sample had normal physicochemical parameters, no
microorganism was isolated and no anti-Brucella antibodies
were detected by agglutination); d) CSF samples from pa-
tients who had meningitis caused by infectious agents other
than Brucella spp. (Staphylococcus aureus and Streptococ-
cus pneumoniae). A written consent was obtained from all
patients and all procedures were approved by the ethics
committee of the IDEHU Institute. Antibodies against
Brucella cytoplasmic proteins and LPS were detected in
CSF and serum samples as described [37]. MMP-9 in CSF
samples was detected by zymography.
Statistical analysis
Statistical analysis was performed with one-way ANOVA,
followed by post hoc Tukey test using GraphPad Prism 4.0
software, San Diego, CA, USA). Data was represented as
mean ± standard error of the mean (SEM).
Results
B. abortus infection induces MMP-9 secretion from
astrocytes
We have previously demonstrated the ability of B. abor-
tus to invade and replicate in primary cultures of mouse
astrocytes [25]. As mentioned, mouse astrocytes can re-
spond to bacterial infections with an enhanced secretion
of MMP [30]. Thus, we decided to investigate whether
B. abortus infection induces MMP expression in mouse
astrocytes. Astrocyte infection resulted in an increased
MMP activity that was detected by zymography in the
supernatants of infected cells at 48 hours post infection,
which according to the molecular weight of the band
corresponded to MMP-9 (Figure 1A). This was confirmed
by ELISA, which revealed significantly (P < 0.001) in-
creased levels of MMP-9 in supernatants of infected cells
as compared to uninfected cells (Figure 1B). In vivo, the ac-
tivity of MMP is counterbalanced by the activity of tissue
inhibitors including tissue inhibitors of metalloproteinases
(TIMP) [38]. Therefore, the net gelatinase or collagenase
activity in a complex sample, such as culture supernatants,
depends on the balance between MMP and TIMP activ-
ities. This net activity is not revealed by zymographic
methods, since MMP-TIMP complexes may dissociate
during gel electrophoresis. To assess whether an increased
net gelatinase activity is generated by Brucella-infected as-
trocytes, culture supernatants from these cells were incu-
bated with a non-fluorescent gelatin-fluorescein conjugate,
and the fluorescence unmasked as a consequence of gelatin
degradation was measured in a fluorometer. The enzymatic
activity (measured as fluorescence intensity) increased sig-
nificantly (P < 0.001) in supernatants of Brucella-infected
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Figure 1 B. abortus induces secretion of MMP-9 from
astrocytes. Astrocytes were infected with B. abortus at different
multiplicities of infection (MOI). MMP-9 production was determined
by zymography (A) and ELISA (B) at 48 hours post infection. For
MMP activities, the supernatants from infected and non-infected
astrocytes were incubated with a fluorescein-conjugated gelatin
substrate that produces highly fluorescent peptides when gelatin is
digested. Data are expressed in fluorescence units informed by the
fluorometer (C). MMP-9, as determined by zymography, was also
induced in astrocytes infected with B. canis, B. melitensis and B. suis
(D). Phorbol myristate acetate (PMA) was used as a positive control.
Bars express the mean ± SEM of duplicates. Data shown are from a
representative experiment of three performed. ***P < 0.001 versus
non-infected (NI) astrocytes.
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By all methods employed, the magnitude of MMP-9 re-
leased to culture supernatants was directly related to
the multiplicities of infection (MOI) used to infect cells.
MMP-9 secretion was not a unique attribute of B. abor-
tus since astrocytes infected with other Brucella species
such as B. canis, B. melitensis and B. suis, were able to
induce MMP-9 secretion (Figure 1D). These results in-
dicate that Brucella infection induces the secretion of
MMP-9 in mouse astrocytes.
B. abortus-induced secretion of MMP-9 in astrocytes is
mediated by L-Omp19, but not by B. abortus LPS
To test whether viable bacteria were necessary to induce
MMP from astrocytes, the ability of heat-killed B. abor-
tus (HKBA) to induce the secretion of MMP-9 was ex-
amined. PMA was used as control. The secretion of
MMP-9 was markedly enhanced in culture supernatants
from astrocytes stimulated with HKBA when compared
with the unstimulated cells, as assessed by zymography
and gelatinolytic activity test (Figure 2A and B, respect-
ively). MMP-9 production was a function of the amount
of bacteria present in the culture. A significant (P < 0.01)
MMP-9 activity was detected in cultures containing be-
tween 1 × 106 and 1 × 109 bacteria/ml, a similar bacterial
concentration that the one able to elicit the secretion of
MMP-9 with live bacteria. These results suggest that the
secretion of MMP-9 could be induced by a structural
component of B. abortus. Since we have previously dem-
onstrated that B. abortus lipoproteins induce cytokine and
MMP secretion in different cells types [15,17,18,25], we
hypothesized that lipoproteins could also mediate such ef-
fects in astrocytes. To investigate this hypothesis we used
recombinant L-Omp19 as a Brucella lipoprotein model
[31]. Astrocytes were incubated with L-Omp19 and cul-
ture supernatants were harvested 48 hours later to meas-
ure the secretion of MMP-9 by zymography, ELISA and
gelatinolytic activity test. L-Omp19 induced a significant
(P < 0.001) secretion of MMP-9 in a dose-dependent
fashion (Figure 2C-E). Independently of the way in which
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dependent on the lipidation of L-Omp19, as U-Omp19
failed to induce the secretion of MMP-9 (Figure 2C and E).
To ascertain whether the effects elicited by L-Omp19
could be extended to all B. abortus lipoproteins, the
production of MMP-9 was also evaluated in astrocytes in-
cubated with a synthetic lipohexapeptide (Pam3Cys) that
mimics the structure of the lipoprotein lipid moiety.
Pam3Cys also stimulated MMP-9 secretion by astrocytes
(Figure 2C and E). These results indicate that the Pam3-
modified cysteine is the molecular structure of L-Omp19
that induces MMP-9 secretion. At variance with the results
obtained with L-Omp19, B. abortus LPS did not induce
MMP-9 production even when used at high doses (1,000
ng/ml) (Figure 2C and E). Altogether, these results indicateN
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HKBA and L-Omp19 induce phosphorylation of p38 and
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MAPK play a key role in the regulation of pro-
inflammatory cytokines and MMP production [30,39].
Thus, we explored the possibility that MAPK could play
a role in mediating MMP-9 secretion, as induced by B.
abortus lipoproteins. As a first step, we investigated
whether p38 and Erk1/2 MAPK were phosphorylated in
astrocytes when these cells were treated with HKBA or
L-Omp19. PMA stimulation was used as a positive con-
trol. Both, HKBA and L-Omp19 induced p38 and Erk1/2
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Figure 3 HKBA and L-Omp19 induce p38 and Erk1/2 phosphorylation in astrocytes. Astrocytes were stimulated with HKBA (A, C), L-Omp19
or U-Omp19 (1,000 ng/ml) (B, D). MAPK phosphorylation was determined by Western blot. Total and phosphorylated Erk1/2 (A, B, upper panels).
Total and phosphorylated p38 (C, D, upper panels). PMA was used as a positive control. Densitometric analysis of results from three independent
experiments as performed in (A-D), lower panels. *P < 0.1, **P < 0.01, ***P < 0.001 for comparisons with non-stimulated (NS) astrocytes. The data
shown are from a representative experiment of three performed.
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lipidation of L-Omp19, as U-Omp19 failed to induce the
activation of both p38 and Erk1/2 MAPK. On the con-
trary, HKBA induced an increase in Jnk1/2 phosphoryl-
ation only at the highest concentration of HKBA tested,
albeit not significantly (Figure 4A).
p38 and Erk1/2 signaling pathways are involved in the
secretion of MMP-9 and TNF-α induced by HKBA and
L-Omp19 in astrocytes
We next investigated whether the specific inhibition of
p38 and Erk1/2 MAPK could inhibit MMP-9 produc-
tion. Therefore, inhibition experiments of the p38 and
Erk1/2 MAPK signaling pathways were performed with
the specific inhibitors SB203580 and PD98059, respect-
ively. Both, p38 and Erk1/2 MAPK pathways partici-
pated in the production of MMP-9 as elicited by HKBA
and L-Omp19. By the zymography or gelatinolytic activ-
ity test, the production of MMP-9 was significantly
inhibited (P < 0.001) either by p38 or Erk1/2 inhibitors,
and was completely abrogated when both inhibitors
were used together (Figure 5A-D). This inhibitory effect
was reproduced when astrocytes were stimulated with
Pam3Cys (Figure 5E). Conversely, inhibition of Jnk1/2
with the specific inhibitor SP600125 had no effect on
HKBA-induced MMP-9 production (Figure 4B). We
had previously established that Brucella lipoproteins in-
duced TNF-α production by astrocytes [25]. To evaluate
whether the increased activation of MAPK p38 and
Erk1/2 induced by stimulation with L-Omp19 may be
involved in the up-regulation of TNF-α, we also ana-
lyzed the effect of kinase inhibitors on the production of
this cytokine. Paralleling MMP-9 results, inhibition of
p38 or Erk1/2, but not Jnk1/2 (Figure 4C), significantly
inhibited (P < 0.001) TNF-α secretion from astrocytes
as elicited by HKBA and L-Omp19, and was completely
abolished when both inhibitors were used in combin-
ation (Figure 6). This indicates that p38 and Erk1/2
MAPK pathways, but not Jnk1/2, could be involved in
pathological responses induced by B. abortus and its li-
poproteins in astrocytes.
TNF-α induces MMP-9 from B. abortus-infected astrocytes
Since a concomitant abrogation of B. abortus- and L-
Omp19-induced TNF-α and MMP-9 production was ob-
served when p38 and Erk1/2 pathways were inhibited
and considering that TNF-α is known to induce theproduction of MMP-9 by other cell types infected with
B. abortus [40], we decided to investigate the role of
TNF-α in MMP-9 secretion. Astrocytes were pre-
incubated with an anti-TNF-α neutralizing antibody or
its isotype control and then infected with B. abortus or
cultured with L-Omp19 or HKBA. The secretion of
MMP-9 was evaluated by zymography and ELISA after
culture. Recombinant TNF-α was used as control. Incuba-
tion of astrocytes with anti-TNF-α significantly inhibited
(P < 0.001) the B. abortus-mediated secretion of MMP-9
at the MOI tested (Figure 7A and B). Anti-TNF-α also
inhibited significantly (P < 0.001) the HKBA- and L-
Omp19-mediated production of MMP-9 (Figure 7C). The
isotype-control antibody had no effect on the response in-
vestigated. As expected, incubation of astrocytes with
anti-TNF-α blocked the TNF-α-mediated MMP-9 secre-
tion (Figure 7C). These results indicate that in astrocytes
the secretion of MMP-9 mediated by B. abortus and its li-
poproteins depends on TNF-α.
Patients suffering neurobrucellosis display MMP-9 activity
in their CSF
Our hypothesis was that B. abortus organisms that have
access to the CNS can cause inflammation, and that this
inflammatory response may lead to tissue damage through,
at least, MMP release. To corroborate our hypothesis and
give clinical relevance to our findings we investigated
whether patients who developed neurobrucellosis exhibit
MMP-9 activity in their CSF. MMP-9 activity, as assayed by
zymography, was absent in CSF samples from non-infected
controls. In contrast, MMP-9 activity was detected in
the three CSF samples from neurobrucellosis patients
(Figure 8B). These patients had a focalized active infec-
tion process since Brucella organisms were recovered
from their CSF samples, which also exhibited high titers
of antibodies against B. abortus LPS and Brucella
cytoplasmic proteins (CP) (Figure 8A). Interestingly, no
MMP-9 activity was detected in the CSF sample from a
patient suffering brucellosis without neurological in-
volvement, in which neither anti-Brucella antibodies
nor the bacterium were detected (Figure 8A and B).
This suggests that, during human brucellosis infection,
MMP-9 is released to the CSF only when Brucella
invades the CNS. Also, CSF samples from patients who
had meningitis caused by infectious agents other than
Brucella spp., exhibited MMP-9 activity (Figure 8B).
These results indicate that astrocyte-secreted MMP-9
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Figure 4 HKBA does not activate Jnk1/2. Astrocytes were stimulated with HKBA. Jnk1/2 phosphorylation was determined by Western blot.
Total and phosphorylated Jnk1/2 (A, upper panel). PMA was used as a positive control. Densitometric analysis of results from three independent
experiments as performed in (A, lower panel). Astrocytes were incubated with Jnk1/2 inhibitor (SP) two hours before the beginning of culture
and kept throughout. Culture supernatants were harvested at 48 hours post stimulation with HKBA to assess the expression of MMP-9 by
zymography (B) or TNF-α by ELISA (C). Bars express the mean ± SEM of duplicates. Data shown are from a representative experiment of three
performed. NS: non-stimulated astrocytes. ***P < 0.001 versus non-stimulated (NS) astrocytes.
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in the pathological manifestations of neurobrucellosis.
Discussion
We have submitted that in neurobrucellosis, inflammation
plays a key role in the mechanism of disease [6,25,41].
The importance of the inflammatory response elicited in
the CNS by Brucella is that it can lead to irreversible CNS
damage of the type that may be attributed to neuronal loss
[6]. Inflammation in the CNS is thought to play a primary
role in the pathogenesis of neurodegenerative diseases
[42]. Given the likely contribution of inflammation to the
pathogenesis of neurobrucellosis, we hypothesized that, as
with some neurodegenerative diseases, these inflammatory
responses may lead to CNS tissue destruction [4,5], and
eventually loss of glial and neuronal cells.
Besides inflammatory cytokines, MMP play an import-
ant role in the inflammatory damage of CNS, since they
can damage the brain parenchyma, the blood-brain barrier
and even kill neurons [11-13]. We have already demon-
strated the central role of the astrocyte in the production
of pro-inflammatory cytokines that cause cell death upon
infection with B. abortus [25]. Yet, astrocytes as a source
of MMP have not been investigated in neurobrucellosis.
In this study, we present evidence indicating that upon
infection with B. abortus, as well as other Brucella spe-
cies, astrocytes secrete MMP-9 to culture supernatants.MMP-9 activity was evidenced by zymography and
ELISA. MMP activity is counterbalanced by the action
of tissue inhibitors including TIMP [38]. Upon infection
or stimulation with inflammatory cytokines, TIMP pro-
duction by astrocytes usually does not increase to the
same extent as that of MMP-9, thus resulting in an in-
creased MMP/TIMP ratio [43]. Supernatants from Bru-
cella-infected astrocytes produced gelatin breakdown
when assayed in fluid phase under native conditions in
which MMP-TIMP complexes are not dissociated, as
occurs during gel electrophoresis. Thus, this assay demon-
strated the presence of a net gelatinase activity in these su-
pernatants, suggesting that the MMP-9 induction detected
in Brucella-infected astrocytes may truly contribute to col-
lagen degradation in brain parenchyma. MMP-2, the other
main metalloproteinase with gelatinase activity, has been
implicated in the pathology associated with CNS infec-
tions [14]. Thus, we also investigated the up-regulation of
both, MMP-2 and MMP-9 in astrocytes. However, under
our experimental conditions B. abortus infection of astro-
cytes did not alter the expression of MMP-2 (not shown).
The production of MMP-9 was not dependent on bac-
terial viability, since it was also induced by exposure to
heat-killed B. abortus (HKBA), suggesting that it was elic-
ited by a structural bacterial component. We established
that the structural element responsible of such response
was not B. abortus LPS. B. abortus possesses lipoproteins
Figure 5 Erk1/2 and p38 MAPK pathways are involved in MMP-9 secretion by HKBA- or L-Omp19-stimulated astrocytes. Astrocytes were
incubated with inhibitors of MAPK pathways (PD: inhibitor of Erk1/2; SB: inhibitor of p38) two hours before the beginning of culture and kept
throughout. Culture supernatants were harvested at 48 hours post stimulation with HKBA, L-Omp19 and Pam3Cys to assess the expression of
MMP-9 by zymography (A) and (B). The net gelatinase activity was expressed in fluorescence units informed by the fluorometer (C, D and E).
Pam3Cys was used as a positive control. Bars express the mean ± SEM of duplicates. Data shown are from a representative experiment of four
performed. NS: non-stimulated astrocytes. *P < 0.05, **P < 0.01, ***P < 0.001 versus untreated (minus sign); and P < 0.05 versus the treatment
with PD or SB alone (black star).
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strated that B. abortus lipoproteins can elicit inflammatory
mediators and MMP-9 from other cell types [15,40].
Thus, we hypothesized that B. abortus lipoproteins could
be the structural components involved in the observed
phenomenon. L-Omp19, a prototypical B. abortus lipo-
protein, induced the secretion of MMP-9 from astrocytes
in a dose-dependent fashion. U-Omp19 had no effect,
demonstrating that acylation of Omp19 is required for its
biological activity. Not only L-Omp19 but also Pam3Cys
was able to induce MMP-9. Since all brucellar lipoproteins
likely share the Pam3Cys modification, this entails that
any lipoprotein should be able to exert this effect. As theB. abortus genome contains no less than 80 genes encod-
ing putative lipoproteins [45], many of which were shown
to be expressed in the outer membrane of the bacterium
[44], one can envision that the local concentration of Bru-
cella lipoproteins in confined tissue spaces within the
brain may be sufficient to exert their biological effects. In
this context, we can hypothesize that any surface-exposed
Brucella lipoprotein may be relevant beyond in vitro as-
says and not one lipoprotein but rather a combination of
them may contribute to MMP-9 secretion elicited by B.
abortus within the brain.
Of note, although both L-Omp-19 and B. abortus
produce increases in MMP-9 from astrocytes, the
αFigure 6 Erk1/2 and p38 MAPK pathways are involved in TNF-α secretion by HKBA- or L-Omp19-stimulated astrocytes. Astrocytes were
incubated with inhibitors of MAPK pathways (PD: inhibitor of Erk1/2; SB: inhibitor of p38) two hours before the beginning and kept throughout
the culture with HKBA (108 bacteria/ml), L-Omp19 (1,000 ng/ml) and U-Omp19 (1,000 ng/ml). Culture supernatants were harvested at 48 hours
post stimulation to assess the secretion of TNF-α by ELISA. Bars express the mean ± SEM of duplicates. Data shown are from a representative
experiment of four performed. NS: non-stimulated astrocytes. ***P < 0.001 versus untreated (minus sign); P < 0.001 versus the treatment with PD
or SB alone (black star).
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http://www.jneuroinflammation.com/content/10/1/47concentration produced by L-Omp-19 is considerable
higher than that produced by B. abortus. The reasons
for this difference are unknown but may relate to the
different bioavailability of L-Omp19 when used as a
highly purified ligand. Lipoproteins present in whole or-
ganisms probably exert their inflammatory action either
when released from living bacteria, likely in a propor-
tion that represents only a fraction of the total amountHKL-Omp19
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Figure 8 Patients with neurobrucellosis display MMP-9 activity in their CSF. CSF and serum samples were obtained from non-infected
controls (C1 and C2), patients who had neurobrucellosis (NB1, NB2 and NB3), a patient who had brucellosis without neurological involvement (Br)
and CSF samples from patients who had meningitis caused by infectious agents other than Brucella spp. (Staphylococcus aureus, SaM, and
Streptococcus spp., SsM). Antibodies against Brucella cytoplasmic proteins (a-CP) and LPS (a-LPS) were detected in CSF and serum samples. Culture
to detect Brucella spp. presence was assayed in CSF (A). MMP-9 in CSF samples was detected by zymography (B). Values in Table A correspond to
antibody titers against CP and LPS. ND: non-determined.
Miraglia et al. Journal of Neuroinflammation 2013, 10:47 Page 12 of 14
http://www.jneuroinflammation.com/content/10/1/47since, as we have put forward, lipoproteins are the main
components of B. abortus-elicited inflammation [31].
Brucellar lipoproteins readily activated p38 and Erk1/2
MAPK, thus enlisting these molecules among the kinase
pathways that B. abortus may address as it invades the
CNS. Our results also demonstrate that both the p38
and the Erk1/2 MAPK pathways participate in the pro-
duction of MMP-9, as elicited by HKBA and L-Omp19.
The Jnk pathway, however, was not involved. Production
of MMP-9 was significantly diminished either with the
p38 or the Erk1/2 inhibitors, and completely abrogated
when both inhibitors were used together. A concomitant
inhibition of TNF-α secretion, as induced by HKBA and
L-Omp19, was also achieved with the p38 or the Erk1/2
inhibitors, and again TNF-α secretion was abolished
when both inhibitors were used. These results indicate
that mouse astrocytes require both the Erk1/2 and
p38 MAPK pathways for optimal lipoprotein-induced
MMP-9 and TNF-α. A requirement for both signaling
pathways for optimal TNF-α and MMP-9 responses
in astrocytes has been previously reported by Ramesh
et al. and Arai et al. [36,46].
Increased MMP-9 secretion is known to be induced by
pro-inflammatory cytokines in a variety of CNS diseases
characterized by tissue destructive pathology [24]. As
TNF-α is known to be a critical factor in the pathologyof neurobrucellosis [25,41], and considering that both
MMP-9 and TNF-α were abrogated when MAPK signal-
ing was inhibited in astrocytes, we investigated the role
of B. abortus-induced TNF-α in the production of
MMP-9. Blocking experiments indicated that TNF-α is
sufficient for astrocyte MMP-9 secretion in response to
B. abortus or its lipoproteins. Although IL-1β was also
vindicated as an inducer of MMP-9 by astrocytes, its
role, when mediated by MAPK signaling, seems to be
important at physiological levels [30]. These levels were
lower than the ones that we have observed when B.
abortus infects astrocytes [25].
High CSF concentrations of cytokines and chemokines
have been reported in neurobrucellosis patients [47].
However, no report has investigated the activity of MMP
in the CSF of such individuals. Giving clinical relevance
to our in vitro studies, CSF from patients suffering from
neurobrucellosis exhibited MMP-9 activity as evaluated
by zymography. Interestingly, MMP-9 presence in CSF
seems to be a feature of an active infection process in
the CNS, since a patient who had brucellosis without
neurological involvement did not display MMP-9 activity
in its CSF sample. This indicates that MMP-9 release is
observed in CSF only when Brucella invades the CNS.
Of note, MMP-9 activity was also present in CSF of pa-
tients suffering from meningitis due to other bacteria
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flammation of brain and spinal cord (encephalomyelitis)
[48,49] as that observed in neurobrucellosis [6].
Finally, our results indicate that TNF-α stimulates
MMP-9 secretion from astrocytes through the MAPK
pathways. Since anti-inflammatory pyridinyl imidazole
drugs such as MAPK inhibitors have been identified as
putative drugs for antiinflammatory therapies [50], as
have therapeutics targeting TNF-α-mediated brain in-
flammation [51], the data presented in this paper suggest
that inhibiting such molecules (MAPK and TNF-α) may
represent pharmaceutical strategies to restrict MMP-9
secretion, thereby potentially reducing morbidity associa-
ted with neurobrucellosis.
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